Regulatory scientific advice in drug development: does company size make a difference?

PURPOSE: To assess whether the content of Scientific Advice (SA) questions addressed to a national drug regulatory agency is associated with company size. This may help to increase understanding about the knowledge, strategic, and regulatory gaps companies face during drug development. METHODOLOGY:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Putzeist, Michelle, Mantel-Teeuwisse, Aukje K., Gispen-De Wied, Christine C., Hoes, Arno W., Leufkens, Hubert G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer-Verlag 2010
Konular:
Pharmacoepidemiology and Prescription
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021701/
https://ncbi.nlm.nih.gov/pubmed/21049297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-010-0919-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller